Frederick W. Driscoll, Chief Financial Officer at Flexion Therapeutics Inc (FLXN), sold 3,000 shares at $23.00 ($69K) on 2017-03-23, disclosed to the SEC on 2017-03-24.
Open-market sale of $69k FLXN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NK | SELL | 2020-08-13 | $1.2M | — | Filing → |
| MEIP | BUY | 2019-12-20 | $100K | — | Filing → |
| FLXN | SELL | 2017-03-02 | $1.3M | — | Filing → |